<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36442393</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-2317</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Redox biology</Title><ISOAbbreviation>Redox Biol</ISOAbbreviation></Journal><ArticleTitle>Sigma-1 receptor agonist PRE-084 confers protection against TAR DNA-binding protein-43 toxicity through NRF2 signalling.</ArticleTitle><Pagination><StartPage>102542</StartPage><MedlinePgn>102542</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102542</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.redox.2022.102542</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-2317(22)00314-7</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting upper and lower motor neurons. As a consequence, ALS patients display a locomotor disorder related to muscle weakness and progressive paralysis. Pathological mechanisms that participate in ALS involve deficient unfolded protein response, mitochondrial dysfunction and oxidative stress, among others. Finding a therapeutic target to break the vicious circle is particularly challenging. Sigma-1 receptor (S1R) is an endoplasmic reticulum (ER) chaperone that may be one of those targets. We here address and decipher the efficiency of S1R activation on a key ALS gene, TDP43, in zebrafish vertebrate model. While expression of mutant TDP43 (TDP43<sup>G348C</sup>) led to locomotor defects, treatment with the reference S1R agonist PRE-084 rescued motor performances in a zebrafish model. Treatment with the agonist ameliorated maximal mitochondrial respiration in the TDP43 context. We observed that TDP43<sup>G348C</sup> exacerbated ER stress induced by tunicamycin, resulting in increased levels of ER stress chaperone BiP and pro-apoptotic factor CHOP. Importantly, PRE-084 treatment in the same condition further heightened BiP levels but also EIF2&#x3b1;/ATF4 and NRF2 signalling cascades, both known to promote antioxidant protection during ER stress. Moreover, we showed that increasing NRF2 levels directly or by sulforaphane treatment rescued locomotor defects of TDP43<sup>G348C</sup> zebrafish. For the first time, we here provide the proof of concept that PRE-084 prevents mutant TDP43 toxicity by boosting ER stress response and antioxidant cascade through NRF2 signalling.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lasbleiz</LastName><ForeName>Christelle</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>MMDN, Univ Montpellier, EPHE, INSERM, Montpellier, France; EPHE, PSL, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peyrel</LastName><ForeName>Amandine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>MMDN, Univ Montpellier, EPHE, INSERM, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarot</LastName><ForeName>Pauline</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>MMDN, Univ Montpellier, EPHE, INSERM, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarniguet</LastName><ForeName>J&#xe9;r&#xf4;me</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>MMDN, Univ Montpellier, EPHE, INSERM, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crouzier</LastName><ForeName>Lucie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>MMDN, Univ Montpellier, EPHE, INSERM, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cubedo</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>MMDN, Univ Montpellier, EPHE, INSERM, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delprat</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>MMDN, Univ Montpellier, EPHE, INSERM, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossel</LastName><ForeName>Mireille</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>MMDN, Univ Montpellier, EPHE, INSERM, Montpellier, France; EPHE, PSL, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maurice</LastName><ForeName>Tangui</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>MMDN, Univ Montpellier, EPHE, INSERM, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li&#xe9;vens</LastName><ForeName>Jean-Charles</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>MMDN, Univ Montpellier, EPHE, INSERM, Montpellier, France. Electronic address: jean-charles.lievens@umontpellier.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Redox Biol</MedlineTA><NlmUniqueID>101605639</NlmUniqueID><ISSNLinking>2213-2317</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C106106">sigma-1 receptor</NameOfSubstance></Chemical><Chemical><RegistryNumber>138847-85-5</RegistryNumber><NameOfSubstance UI="C071738">2-(4-morpholino)ethyl-1-phenylcyclohexane-1-carboxylate</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051267">NF-E2-Related Factor 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015027" MajorTopicYN="N">Zebrafish</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051267" MajorTopicYN="N">NF-E2-Related Factor 2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059865" MajorTopicYN="N">Endoplasmic Reticulum Stress</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of competing interest The Authors declare to have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>28</Day><Hour>18</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36442393</ArticleId><ArticleId IdType="pmc">PMC9706169</ArticleId><ArticleId IdType="doi">10.1016/j.redox.2022.102542</ArticleId><ArticleId IdType="pii">S2213-2317(22)00314-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Miller R.G., Mitchell J.D., Moore D.H. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) Cochrane Database Syst. Rev. 2012;3 doi: 10.1002/14651858.CD001447.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001447.pub3</ArticleId><ArticleId IdType="pmc">PMC7055506</ArticleId><ArticleId IdType="pubmed">22419278</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B., Gendron T., Staff N. Amyotrophic lateral sclerosis: an update for 2018. Mayo Clin. Proc. 2018;93 doi: 10.1016/j.mayocp.2018.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2018.04.007</ArticleId><ArticleId IdType="pubmed">30401437</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil B., Li&#xe9;vens J.-C. Mitochondrial quality control in amyotrophic lateral sclerosis: towards a common pathway? Neural Regen. Res. 2017;12:1052&#x2013;1061. doi: 10.4103/1673-5374.211179.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.211179</ArticleId><ArticleId IdType="pmc">PMC5558479</ArticleId><ArticleId IdType="pubmed">28852382</ArticleId></ArticleIdList></Reference><Reference><Citation>Laferriere F., Polymenidou M. Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis. Swiss Med. Wkly. 2015;145 doi: 10.4414/smw.2015.14054.</Citation><ArticleIdList><ArticleId IdType="doi">10.4414/smw.2015.14054</ArticleId><ArticleId IdType="pubmed">25635517</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne A.N., Zaepfel B.L., Zarnescu D.C. Failure to deliver and translate&#x2014;new insights into RNA dysregulation in ALS. Front. Cell. Neurosci. 2017;11 doi: 10.3389/fncel.2017.00243.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00243</ArticleId><ArticleId IdType="pmc">PMC5562674</ArticleId><ArticleId IdType="pubmed">28860970</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurice T. Bi-phasic dose response in the preclinical and clinical developments of sigma-1 receptor ligands for the treatment of neurodegenerative disorders. Expet Opin. Drug Discov. 2021;16:373&#x2013;389. doi: 10.1080/17460441.2021.1838483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17460441.2021.1838483</ArticleId><ArticleId IdType="pubmed">33070647</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi T., Maurice T., Su T.P. Ca(2+) signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca(2+) concentration. J. Pharmacol. Exp. Therapeut. 2000;293:788&#x2013;798.</Citation><ArticleIdList><ArticleId IdType="pubmed">10869377</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi T., Su T.-P. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell. 2007;131:596&#x2013;610. doi: 10.1016/j.cell.2007.08.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.08.036</ArticleId><ArticleId IdType="pubmed">17981125</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagashira H., Bhuiyan M.S., Shioda N., Fukunaga K. Fluvoxamine rescues mitochondrial Ca2+ transport and ATP production through &#x3c3;(1)-receptor in hypertrophic cardiomyocytes. Life Sci. 2014;95:89&#x2013;100. doi: 10.1016/j.lfs.2013.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2013.12.019</ArticleId><ArticleId IdType="pubmed">24373833</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso G., Phan V., Guillemain I., Saunier M., Legrand A., Anoal M., Maurice T. Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system. Neuroscience. 2000;97:155&#x2013;170. doi: 10.1016/s0306-4522(00)00014-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0306-4522(00)00014-2</ArticleId><ArticleId IdType="pubmed">10771347</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori T., Hayashi T., Hayashi E., Su T. Sigma-1 receptor chaperone at the ER-mitochondrion interface mediates the mitochondrion-ER-nucleus signaling for cellular survival. PLoS One. 2013;8 doi: 10.1371/journal.pone.0076941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0076941</ArticleId><ArticleId IdType="pmc">PMC3799859</ArticleId><ArticleId IdType="pubmed">24204710</ArticleId></ArticleIdList></Reference><Reference><Citation>Su T.-P., Su T.-C., Yoki N., Shang-Yi T. The sigma-1 receptor as a pluripotent modulator in living systems. Trends Pharmacol. Sci. 2016;37:262&#x2013;278. doi: 10.1016/j.tips.2016.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2016.01.003</ArticleId><ArticleId IdType="pmc">PMC4811735</ArticleId><ArticleId IdType="pubmed">26869505</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai S.-Y., Rothman R.K., Su T.-P. Insights into the Sigma-1 receptor chaperone's cellular functions: a microarray report. Synapse. 2012;66:42&#x2013;51. doi: 10.1002/syn.20984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/syn.20984</ArticleId><ArticleId IdType="pmc">PMC3705961</ArticleId><ArticleId IdType="pubmed">21905129</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Shanmugam A., Markand S., Zorrilla E., Ganapathy V., Smith S.B. Sigma 1 receptor regulates the oxidative stress response in primary retinal M&#xfc;ller glial cells via NRF2 signaling and system xc(-), the Na(+)-independent glutamate-cystine exchanger. Free Radic. Biol. Med. 2015;86:25&#x2013;36. doi: 10.1016/j.freeradbiomed.2015.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2015.04.009</ArticleId><ArticleId IdType="pmc">PMC4554890</ArticleId><ArticleId IdType="pubmed">25920363</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Zhao J., Cui X., Mysona B.A., Navneet S., Saul A., Ahuja M., Lambert N., Gazaryan I.G., Thomas B., Bollinger K.E., Smith S.B. The molecular chaperone sigma 1 receptor mediates rescue of retinal cone photoreceptor cells via modulation of NRF2. Free Radic. Biol. Med. 2019;134:604&#x2013;616. doi: 10.1016/j.freeradbiomed.2019.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2019.02.001</ArticleId><ArticleId IdType="pmc">PMC6619428</ArticleId><ArticleId IdType="pubmed">30743048</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao H., Wang J., Saul A., Smith S.B. Comparison of neuroprotective effects of monomethylfumarate to the sigma 1 receptor ligand (+)-Pentazocine in a murine model of retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 2020;61:5. doi: 10.1167/iovs.61.3.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.61.3.5</ArticleId><ArticleId IdType="pmc">PMC7401726</ArticleId><ArticleId IdType="pubmed">32150247</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu U.B., Ruoho A.E. Biochemical pharmacology of the sigma-1 receptor. Mol. Pharmacol. 2016;89:142&#x2013;153. doi: 10.1124/mol.115.101170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.115.101170</ArticleId><ArticleId IdType="pubmed">26560551</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai S.-Y.A., Chuang J.-Y., Tsai M.-S., Wang X.-F., Xi Z.-X., Hung J.-J., Chang W.-C., Bonci A., Su T.-P. Sigma-1 receptor mediates cocaine-induced transcriptional regulation by recruiting chromatin-remodeling factors at the nuclear envelope. Proc. Natl. Acad. Sci. U. S. A. 2015;112:E6562&#x2013;E6570. doi: 10.1073/pnas.1518894112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1518894112</ArticleId><ArticleId IdType="pmc">PMC4664336</ArticleId><ArticleId IdType="pubmed">26554014</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee P., Li&#xe9;vens J.-C., Wang S., Chuang J., Khalil B., Wu H., Chang W.-C., Maurice T., Su T.-P. Sigma-1 receptor chaperones rescue nucleocytoplasmic transport deficit seen in cellular and Drosophila ALS/FTD models. Nat. Commun. 2020;11 doi: 10.1038/s41467-020-19396-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19396-3</ArticleId><ArticleId IdType="pmc">PMC7642387</ArticleId><ArticleId IdType="pubmed">33149115</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Saif A., Al-Mohanna F., Bohlega S. A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann. Neurol. 2011;70:913&#x2013;919. doi: 10.1002/ana.22534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22534</ArticleId><ArticleId IdType="pubmed">21842496</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S., Ilieva H., Tamada H., Nomura H., Komine O., Endo F., Jin S., Mancias P., Kiyama H., Yamanaka K. Mitochondria-associated membrane collapse is a common pathomechanism in SIGMAR1- and SOD1-linked ALS. EMBO Mol. Med. 2016;8:1421&#x2013;1437. doi: 10.15252/emmm.201606403.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201606403</ArticleId><ArticleId IdType="pmc">PMC5167132</ArticleId><ArticleId IdType="pubmed">27821430</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavlyutov T.A., Epstein M.L., Verbny Y.I., Huerta M.S., Zaitoun I., Ziskind-Conhaim L., Ruoho A.E. Lack of sigma-1 receptor exacerbates ALS progression in mice. Neuroscience. 2013;240:129&#x2013;134. doi: 10.1016/j.neuroscience.2013.02.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2013.02.035</ArticleId><ArticleId IdType="pmc">PMC3665351</ArticleId><ArticleId IdType="pubmed">23458708</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R., Oliv&#xe1;n S., Rando A., Casas C., Osta R., Navarro X. Sigma-1R agonist improves motor function and motoneuron survival in ALS mice. Neurotherapeutics. 2012;9:814&#x2013;826. doi: 10.1007/s13311-012-0140-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-012-0140-y</ArticleId><ArticleId IdType="pmc">PMC3480575</ArticleId><ArticleId IdType="pubmed">22935988</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono Y., Tanaka, Takata M., Nagahara Y., Noda Y., Tsuruma K., Shimazawa M., Hozumi I., Hara H. SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models. Neurosci. Lett. 2014;559:174&#x2013;178. doi: 10.1016/j.neulet.2013.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2013.12.005</ArticleId><ArticleId IdType="pubmed">24334165</ArticleId></ArticleIdList></Reference><Reference><Citation>Ionescu A., Gradus T., Altman T., Maimon R., Saraf Avraham N., Geva M., Hayden M., Perlson E. Targeting the sigma-1 receptor via pridopidine ameliorates central features of ALS pathology in a SOD1G93A model. Cell Death Dis. 2019;10:210. doi: 10.1038/s41419-019-1451-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1451-2</ArticleId><ArticleId IdType="pmc">PMC6397200</ArticleId><ArticleId IdType="pubmed">30824685</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaja-Capdevila N., Hern&#xe1;ndez N., Navarro X., Herrando-Grabulosa M. Sigma-1 receptor is a pharmacological target to promote neuroprotection in the SOD1G93A ALS mice. Front. Pharmacol. 2021;12 doi: 10.3389/fphar.2021.780588.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.780588</ArticleId><ArticleId IdType="pmc">PMC8702863</ArticleId><ArticleId IdType="pubmed">34955848</ArticleId></ArticleIdList></Reference><Reference><Citation>Couly S., Khalil B., Viguier V., Roussel J., Maurice T., Li&#xe9;vens J.-C. Sigma-1 receptor is a key genetic modulator in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2020;29:529&#x2013;540. doi: 10.1093/hmg/ddz267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz267</ArticleId><ArticleId IdType="pubmed">31696229</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami K. Transposon tools and methods in zebrafish. Dev. Dynam. 2005;234:244&#x2013;254. doi: 10.1002/dvdy.20516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dvdy.20516</ArticleId><ArticleId IdType="pubmed">16110506</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacino T., Zerbo R.A., Balbi M., Torazza C., Frumento G., Fedele E., Bonanno G., Milanese M. Nearly 30 Years of animal models to study amyotrophic lateral sclerosis: a historical overview and future perspectives. Int. J. Mol. Sci. 2021;22 doi: 10.3390/ijms222212236.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222212236</ArticleId><ArticleId IdType="pmc">PMC8619465</ArticleId><ArticleId IdType="pubmed">34830115</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Kobayashi M., Kaneko H., Nakajima-Takagi Y., Nakayama Y., Yamamoto M. Molecular evolution of Keap1. Two Keap1 molecules with distinctive intervening region structures are conserved among fish. J. Biol. Chem. 2008;283:3248&#x2013;3255. doi: 10.1074/jbc.M708702200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M708702200</ArticleId><ArticleId IdType="pubmed">18057000</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2&#x2212;&#x394;&#x394;CT method. Methods. 2001;25:402&#x2013;408. doi: 10.1006/meth.2001.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin J., Arganda-Carreras I., Frise E., Kaynig V., Longair M., Pietzsch T., Preibisch S., Rueden C., Saalfeld S., Schmid B., Tinevez J.-Y., James White D., Hartenstein V., Eliceiri K., Tomancak P., Cardona A. Fiji: an open-source platform for biological-image analysis. Nat. Methods. 2012;9:676&#x2013;682. doi: 10.1038/nmeth.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2019</ArticleId><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>Crouzier L., Richard E., Diez C., Alzaeem H., Denus M., Cubedo N., Delaunay T., Glendenning E., Baxendale S., Li&#xe9;vens J.-C., Whitfield T., Maurice T., Delprat B. Morphological, behavioral and cellular analyses revealed different phenotypes in Wolfram syndrome wfs1a and wfs1b zebrafish mutant lines. Hum. Mol. Genet. 2022;31:2711&#x2013;2727. doi: 10.1093/hmg/ddac065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddac065</ArticleId><ArticleId IdType="pmc">PMC9402244</ArticleId><ArticleId IdType="pubmed">35325133</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccaro A., Patten S.A., Aggad D., Julien C., Maios C., Kabashi E., Drapeau P., Parker J.A. Pharmacological reduction of ER stress protects against TDP-43 neuronal toxicity in vivo. Neurobiol. Dis. 2013;55:64&#x2013;75. doi: 10.1016/j.nbd.2013.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.03.015</ArticleId><ArticleId IdType="pubmed">23567652</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasai S., Shimizu S., Tatara Y., Mimura J., Itoh K. Regulation of Nrf2 by mitochondrial reactive oxygen species in physiology and pathology. Biomolecules. 2020;10:E320. doi: 10.3390/biom10020320.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10020320</ArticleId><ArticleId IdType="pmc">PMC7072240</ArticleId><ArticleId IdType="pubmed">32079324</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasai S., Yamazaki H., Tanji K., Engler M., Matsumiya T., Itoh K. Role of the ISR-ATF4 pathway and its cross talk with Nrf2 in mitochondrial quality control. J. Clin. Biochem. Nutr. 2019;64 doi: 10.3164/jcbn.18-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.3164/jcbn.18-37</ArticleId><ArticleId IdType="pmc">PMC6348405</ArticleId><ArticleId IdType="pubmed">30705506</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarcinelli C., Dragic H., Piecyk M., Barbet V., Duret C., Barthelaix A., Ferraro-Peyret C., Fauvre J., Renno T., Chaveroux C., Mani&#xe9; S.N. ATF4-Dependent NRF2 transcriptional regulation promotes antioxidant protection during endoplasmic reticulum stress. Cancers. 2020;12:E569. doi: 10.3390/cancers12030569.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12030569</ArticleId><ArticleId IdType="pmc">PMC7139862</ArticleId><ArticleId IdType="pubmed">32121537</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuse Y., Nguyen V.T., Kobayashi M. Nrf2-dependent protection against acute sodium arsenite toxicity in zebrafish. Toxicol. Appl. Pharmacol. 2016;305:136&#x2013;142. doi: 10.1016/j.taap.2016.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.taap.2016.06.012</ArticleId><ArticleId IdType="pubmed">27306194</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukaigasa K., Tsujita T., Nguyen V.T., Li L., Yagi H., Fuse Y., Nakajima-Takagi Y., Kato K., Yamamoto M., Kobayashi M. Nrf2 activation attenuates genetic endoplasmic reticulum stress induced by a mutation in the phosphomannomutase 2 gene in zebrafish. Proc. Natl. Acad. Sci. U.S.A. 2018;115:2758&#x2013;2763. doi: 10.1073/pnas.1714056115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1714056115</ArticleId><ArticleId IdType="pmc">PMC5856520</ArticleId><ArticleId IdType="pubmed">29472449</ArticleId></ArticleIdList></Reference><Reference><Citation>Glancy B., Balaban R.S. Role of mitochondrial Ca2+ in the regulation of cellular energetics. Biochemistry. 2012;51:2959&#x2013;2973. doi: 10.1021/bi2018909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi2018909</ArticleId><ArticleId IdType="pmc">PMC3332087</ArticleId><ArticleId IdType="pubmed">22443365</ArticleId></ArticleIdList></Reference><Reference><Citation>Denton R.M. Regulation of mitochondrial dehydrogenases by calcium ions. Biochim. Biophys. Acta. 2009;1787:1309&#x2013;1316. doi: 10.1016/j.bbabio.2009.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2009.01.005</ArticleId><ArticleId IdType="pubmed">19413950</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Wang L., Lu J., Siedlak S.L., Fujioka H., Liang J., Jiang S., Ma X., Jiang Z., da Rocha E.L., Sheng M., Choi H., Lerou P.H., Li H., Wang X. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat. Med. 2016;22:869&#x2013;878. doi: 10.1038/nm.4130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4130</ArticleId><ArticleId IdType="pmc">PMC4974139</ArticleId><ArticleId IdType="pubmed">27348499</ArticleId></ArticleIdList></Reference><Reference><Citation>Goguadze N., Zhuravliova E., Morin D., Mikeladze D., Maurice T. Sigma-1 receptor agonists induce oxidative stress in mitochondria and enhance complex I activity in physiological condition but protect against pathological oxidative stress. Neurotox. Res. 2019;35:1&#x2013;18. doi: 10.1007/s12640-017-9838-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-017-9838-2</ArticleId><ArticleId IdType="pubmed">29127580</ArticleId></ArticleIdList></Reference><Reference><Citation>de Mena L., Lopez-Scarim J., Rincon-Limas D.E. TDP-43 and ER stress in neurodegeneration: friends or foes? Front. Mol. Neurosci. 2021;14 doi: 10.3389/fnmol.2021.772226.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2021.772226</ArticleId><ArticleId IdType="pmc">PMC8573113</ArticleId><ArticleId IdType="pubmed">34759799</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H., Matsuoka M. TDP-43 toxicity is mediated by the unfolded protein response-unrelated induction of C/EBP homologous protein expression. J. Neurosci. Res. 2012;90 doi: 10.1002/jnr.22777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.22777</ArticleId><ArticleId IdType="pubmed">22057717</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutihac R., Alegre-Abarrategui J., Gordon D., Farrimond L., Yamasaki-Mann M., Talbot K., Wade-Martins R. TARDBP pathogenic mutations increase cytoplasmic translocation of TDP-43 and cause reduction of endoplasmic reticulum Ca2+ signaling in motor neurons. Neurobiol. Dis. 2015;75:64&#x2013;77. doi: 10.1016/j.nbd.2014.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.12.010</ArticleId><ArticleId IdType="pubmed">25526708</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong J., Huang C., Bi F., Wu Q., Huang B., Zhou H. XBP1 depletion precedes ubiquitin aggregation and Golgi fragmentation in TDP-43 transgenic rats. J. Neurochem. 2012;123:406&#x2013;416. doi: 10.1111/jnc.12014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12014</ArticleId><ArticleId IdType="pmc">PMC3534861</ArticleId><ArticleId IdType="pubmed">22970712</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker A.K., Soo K.Y., Sundaramoorthy V., Parakh S., Ma Y., Farg M.A., Wallace R.H., Crouch P.J., Turner B.J., Horne M.K., Atkin J.D. ALS-associated TDP-43 induces endoplasmic reticulum stress, which drives cytoplasmic TDP-43 accumulation and stress granule formation. PLoS One. 2013;8 doi: 10.1371/journal.pone.0081170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0081170</ArticleId><ArticleId IdType="pmc">PMC3843686</ArticleId><ArticleId IdType="pubmed">24312274</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Zhou S., Ding X., Ma M., Zhang J., Zhou Y., Wu E., Teng J. Activation of ER stress and autophagy induced by TDP-43 A315T as pathogenic mechanism and the corresponding histological changes in skin as potential biomarker for ALS with the mutation. Int. J. Biol. Sci. 2015;11:1140&#x2013;1149. doi: 10.7150/ijbs.12657.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.12657</ArticleId><ArticleId IdType="pmc">PMC4551750</ArticleId><ArticleId IdType="pubmed">26327808</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu W., Liu X., Wang S., Sun G., Zhao R., Lu H. SecinH3 attenuates TDP-43 p.Q331K-induced neuronal toxicity by suppressing endoplasmic reticulum stress and enhancing autophagic flux. IUBMB Life. 2019;71:192&#x2013;199. doi: 10.1002/iub.1951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.1951</ArticleId><ArticleId IdType="pubmed">30376609</ArticleId></ArticleIdList></Reference><Reference><Citation>Oyadomari S., Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 2004;11:381&#x2013;389. doi: 10.1038/sj.cdd.4401373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cdd.4401373</ArticleId><ArticleId IdType="pubmed">14685163</ArticleId></ArticleIdList></Reference><Reference><Citation>Sano R., Reed J.C. ER stress-induced cell death mechanisms. Biochim. Biophys. Acta. 2013;1833:3460&#x2013;3470. doi: 10.1016/j.bbamcr.2013.06.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2013.06.028</ArticleId><ArticleId IdType="pmc">PMC3834229</ArticleId><ArticleId IdType="pubmed">23850759</ArticleId></ArticleIdList></Reference><Reference><Citation>Crouzier L., Richard E.M., Sourbron J., Lagae L., Maurice T., Delprat B. Use of zebrafish models to boost research in rare genetic diseases. Int. J. Mol. Sci. 2021;22:13356. doi: 10.3390/ijms222413356.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222413356</ArticleId><ArticleId IdType="pmc">PMC8706563</ArticleId><ArticleId IdType="pubmed">34948153</ArticleId></ArticleIdList></Reference><Reference><Citation>Barwick S.R., Siddiq M.S., Wang J., Xiao H., Marshall B., Perry E., Smith S.B. Sigma 1 receptor Co-localizes with NRF2 in retinal photoreceptor cells. Antioxidants. 2021;10:981. doi: 10.3390/antiox10060981.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10060981</ArticleId><ArticleId IdType="pmc">PMC8234060</ArticleId><ArticleId IdType="pubmed">34205384</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C.-C., Zhang Y., Umoh M.E., Vaughan S.W., Lorenzini I., Liu F., Sayegh M., Donlin-Asp P.G., Chen Y.H., Duong D.M., Seyfried N.T., Powers M.A., Kukar T., Hales C.M., Gearing M., Cairns Nigel J., Boylan K.B., Dickson D.W., Rademakers R., Zhang Y.-J., Petrucelli L., Sattler R., Zarnescu D.C., Glass J.D., Rossoll W. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci. 2018;21:228&#x2013;239. doi: 10.1038/s41593-017-0047-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0047-3</ArticleId><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Pakos-Zebrucka K., Koryga I., Mnich K., Ljujic M., Samali A., Gorman A.M. The integrated stress response. EMBO Rep. 2016;17:1374&#x2013;1395. doi: 10.15252/embr.201642195.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201642195</ArticleId><ArticleId IdType="pmc">PMC5048378</ArticleId><ArticleId IdType="pubmed">27629041</ArticleId></ArticleIdList></Reference><Reference><Citation>Quir&#xf3;s P.M., Prado M.A., Zamboni N., D'Amico D., Williams R.W., Finley D., Gygi S.P., Auwerx J. Multi-omics analysis identifies ATF4 as a key regulator of the mitochondrial stress response in mammals. J. Cell Biol. 2017;216:2027&#x2013;2045. doi: 10.1083/jcb.201702058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201702058</ArticleId><ArticleId IdType="pmc">PMC5496626</ArticleId><ArticleId IdType="pubmed">28566324</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwak M.-K., Wakabayashi N., Itoh K., Motohashi H., Yamamoto M., Kensler T.W. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J. Biol. Chem. 2003;278:8135&#x2013;8145. doi: 10.1074/jbc.M211898200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M211898200</ArticleId><ArticleId IdType="pubmed">12506115</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamoto N., Izumi H., Miyamoto R., Bin H., Kondo H., Tawara A., Sasaguri Y., Kohno K. Transcriptional regulation of activating transcription factor 4 under oxidative stress in retinal pigment epithelial ARPE-19/HPV-16 cells. Invest. Ophthalmol. Vis. Sci. 2011;52:1226&#x2013;1234. doi: 10.1167/iovs.10-5775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.10-5775</ArticleId><ArticleId IdType="pubmed">21087962</ArticleId></ArticleIdList></Reference><Reference><Citation>He C., et al. Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation. J. Biol. Chem. 2001;276 doi: 10.1074/jbc.M101198200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M101198200</ArticleId><ArticleId IdType="pubmed">11274184</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye P., Gong P., Hu B., Stewart D., Choi M., Choi A., Alam J. Nrf2- and ATF4-dependent upregulation of xCT modulates the sensitivity of T24 bladder carcinoma cells to proteasome inhibition. Mol. Cell Biol. 2014;34:3421&#x2013;3434. doi: 10.1128/MCB.00221-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00221-14</ArticleId><ArticleId IdType="pmc">PMC4135628</ArticleId><ArticleId IdType="pubmed">25002527</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>